Display Settings:

Format

Send to:

Choose Destination
    Curr Pain Headache Rep. 2002 Apr;6(2):147-50.

    Butalbital-containing agents: should they be banned? No.

    Source

    Montefiore Medical Center, 111 East 210th Street, Bronx, NY 10467, USA. sysol@earthlink.net

    Abstract

    Butalbital compounds are of proven efficacy in the treatment of tension headache. Decades of experience have established their value in the treatment of other mild-to-moderate headaches. Untold numbers of people rely on these medications as their drug of choice or use them when vasoconstrictors, opioids, or nonsteroidal anti-inflammatory agents are contraindicated. The medications are cost-effective with only occasional and minor immediate adverse effects. Their overuse may cause the evolution of episodic primary headaches to chronic daily headaches; however, removal of these agents from the market would reduce the chronic daily headache in the general population by a small fraction of 1%.

    PMID:
    11872186
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk